Telix Pharmaceuticals Limited
MELBOURNE, Australia, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into a commercial distribution agreement with Global Medical Solutions Australia (GMSA), for Telixâs prostate cancer imaging product Illuccix® (Kit for the preparation of 68Ga-PSMA-11) for the Australian market.
GMSA is a global manufacturer and distributor of diagnostic and therapeutic radiopharmaceutical...
>>> Read more: Telix Enters Commercial Distribution Agreement for Illuccix® in Australia
MELBOURNE, Australia, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into a commercial distribution agreement with Global Medical Solutions Australia (GMSA), for Telixâs prostate cancer imaging product Illuccix® (Kit for the preparation of 68Ga-PSMA-11) for the Australian market.
GMSA is a global manufacturer and distributor of diagnostic and therapeutic radiopharmaceutical...
>>> Read more: Telix Enters Commercial Distribution Agreement for Illuccix® in Australia
